Clinical trial
A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept…
NCT00353119 · Innovaderm Research Inc., Other · Completed
Key facts
| NCT number | NCT00353119 |
|---|---|
| Title | A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis |
| Official title | Phase 3 Study With a Placebo-Controlled, Double-blind, on the Safety and Efficacy of Etanercept in Palmo-Plantar Pustulosis |
| Lead sponsor | Innovaderm Research Inc., Other |
| Collaborators | Amgen Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Palmoplantaris Pustulosis |
| Intervention type | Drug |
| Interventions | Placebo comparator, Etanercept |
| Enrollment | 15 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Jul 17, 2006 |
| Last update posted | Sep 9, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: